Oxidative stress induces urokinase-type plasminogen activator in RC-K8 human malignant lymphoma cells and H69 human small cell lung carcinoma cells

Fibrinolysis and Proteolysis

Volumn 14, Issue 6, 2000, Pages 366-373

  Miyazono, T ^a,c   Niiya, K ^a   Kiguchi, T ^b   Minemura, M ^b   Harada, M ^c   Watanabe, A ^c  

^a TOYAMA MEDICAL AND PHARMACEUTICAL UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CYCLOHEXIMIDE; HYDROGEN PEROXIDE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MENADIONE; MESSENGER RNA; PLASMINOGEN ACTIVATOR; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UROKINASE;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HALF LIFE TIME; HUMAN; HUMAN CELL; INFLAMMATION; LUNG SMALL CELL CANCER; LYMPHOMA CELL; NORTHERN BLOTTING; OXIDATION; OXIDATIVE STRESS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; SECOND MESSENGER; SIGNAL TRANSDUCTION;

EID: 0034524715     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1054/fipr.2000.0095     Document Type: Article

References (32)

1. Emeis JJ, Verheijen JH, Ronday HK, de Maat PM, Brakman P. Progress in clinical fibrinolysis. Fibrinolysis & Proteolysis 1997; 11: 67-84.
2. Carmeliet P, Collen D. Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system. Thromb Haemost 1995; 74: 429-436.
3. Schmitt M, Harbeck N, Thomssen C et al. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 1997; 78: 285-296.
4. Quax PH, van den Hoogen CM, Verheijen JH et al. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 1990; 265: 15560-15563.
5. Niedbala MJ, Stein M. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells. Biomed Biochim Acta 1991; 50: 427-436.
6. Marshall BC, Xu QP, Rao NV, Brown BR, Hoidal JR. Pulmonary epithelial cell urokinase-type plasminogen activator. Induction by interleukin-1 beta and tumor necrosis factor-alpha. J Biol Chem 1992; 267: 11462-11469.
7. Gyetko MR, Wilkinson CC, Sitrin RG. Monocyte urokinase expression: modulation by interleukins. J Leukocyte Biol 1993; 53: 598-601.
8. Busso N, Nicodeme E, Chesne C, Guillouzo A, Belin D, Hyafil F. Urokinase and type I plasminogen activator inhibitor production by normal human hepatocytes: modulation by inflammatory agents. Hepatology 1994; 20: 186-190.
9. Wojta J, Zoellner H, Gallicchio M, Filonzi EL, Hamilton JA, McGrath K. Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro. Lymphokine Cytokine Res 1994; 13: 133-138.
10. Niiya K, Shinbo M, Ozawa T, Hayakawa Y, Sakuragawa N. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8. Thromb Haemost 1995; 74: 1511-1515.
11. Winrow VR, Winyard PG, Morris CJ, Blake DR. Free radicals in inflammation: second messengers and mediators of tissue destruction. Br Med Bull 1993; 49: 506-522.
12. Hakim J. Reactive oxygen species and inflammation. C R Seances Soc Biol Fil 1993; 187: 286-295.
13. Radeke HH, Meier B, Topley N, Floge J, Habermehl CG, Resch K. Interleukin 1-α and tumor necrosis factor-α induce oxygen radical production in mesangial cells. J Clin Invest 1990; 37: 767-775.
14. Feng L, Xia Y, Garcia GE, Hwang D, Wilson CB. Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest 1995; 95: 1669-1675.
15. Rizzardini M, Carelli M, Cabello Porras R, Cantoni L. Mechanisms of endotoxin-induced haem oxygenase mRNA accumulation in mouse liver: synergism by glutathione depletion and protection by N-acetylcysteine. Biochem J 1994; 304: 477-483.
16. Hansen SK, Nerlov C, Zabel U. A novel complex between the p65 subunit of NF-kappa B and c-Rel binds to a DNA element inviolved in the phorbol ester induction of the human urokinase gene. EMBOJ 1992; 11: 205-213.
17. Novak U, Cocks BG, Hamilton JA. A labile repressor acts through the NFkB-like binding sites of the human urokinase gene. Nucleic Acids Res 1991; 19: 3389-3393.
18. Niiya K, Nsimba M, Hayashi T, Sakuragawa N. Down-regulation of urokinase secretion from a human lymphoma cell line RC-K8 by dexamethasone without inducing plasminogen activator inhibitors. Thromb Res 1992; 65: 311-321.
19. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
20. Granelli-Piperno A, Reich E. A Study of proteases and proteases-inhibitor complexes in biological fluids. J Exp Med 1978; 148: 223-234.
21. Sambrook J, Fritsh EF, Maniatis T. Molecular cloning, a laboratory manual, 2nd edn. Cold Spring Harbor: Cold Spring Harbor Laboratory, 1989; 7.39-7.52.
22. Shinbo M, Niiya K, al-Mokdad M et al. Protein kinase activity-dependent inhibition of urokinase-type plasminogen activator gene transcription by cyclic AMP in human pre-B lymphoma cell line RC-K8. Biochim Biophys Acta 1995; 1268: 293-299.
23. Tanaka F, Ogura N, Abiko Y. Stimulation of plasminogen activtor/plasmin system in gingival fibroblast cells by oxygen radicals. Archs Oral Biol 1997; 42: 263-270.
24. Oka H, Kugiyama K, Doi H, Matsumura T, Shibata H, Miles LA, Sugiyama S, Yasue H. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway. Arterioscler Thromb Vasc Biol 2000; 20: 244-250.
25. Niiya K, Takeuchi T, Kobayashi M, Miyoshi I, Hayashi T, Sakuragawa N. Dexamethasone and phorbol ester, but not cytokines, increase the production of plasminogen activator inhibitor type-2 in the PL-21 human promyelocytic leukemia cell line. Thromb Haemost 1991; 66: 232-238.
26. Sacks T, Moldow CF, Craddock RP, Bowers TK, Jakob HS. Oxygen radicals mediate endothelial cell damage by complement stimulated glanulocytes. J Clin Invest 1978; 61: 1161-1167.
27. Martin WJ II. Neutrophils kill pulmonary endothelial cells by a hydrogen peroxide dependent pathway. An in vitro model of neutrophil mediated lung injury. Ann Rev Respir Dis 1984; 130: 209-213.
28. Niiya K, Ozawa T, Tsuzawa T, Ueshima S, Matsuo O, Sakuragawa N. Transcriptional regulation of urokinase-type plasminogen activator receptor by cyclic AMP in PL-21 human myeloid leukemia cells: comparison with the regulation by phorbol myristate acetate. Thromb Haemost 1998; 79: 574-578.
29. Baeuerle PA, Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988; 242: 540-546.
30. Bergelson S, Pinkus R, Daniel V. Intracellular glutathione levels regulate Fos/Jun induction and activation of glutathione S-transferase gene expression. Cancer Res 1994; 54: 36-40.
31. Pinkus R, Weiner LM, Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kB, and Glutathione S-transferase gene expression. J Biol Chem 1996; 271: 13422-13429.
32. Besser D, Verde P, Nagamine Y, Blasi F. Signal transduction and the u-PA/u-PAR system. Fibrinolysis 1996; 10: 215-237.